Changes in Wnt and TGF-β Signaling Mediate the Development of Regorafenib Resistance in Hepatocellular Carcinoma Cell Line HuH7-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Changes in Wnt and TGF-β Signaling Mediate the Development of Regorafenib Resistance in Hepatocellular Carcinoma Cell Line HuH7

Published:2021-08-11 Issue: Volume:9 Page:
ISSN:2296-634X
Container-title:Frontiers in Cell and Developmental Biology
language:
Short-container-title:Front. Cell Dev. Biol.

Author:

Karabicici Mustafa,Azbazdar Yagmur,Ozhan Gunes,Senturk Serif,Firtina Karagonlar Zeynep,Erdal Esra

Abstract

Graphical AbstractWnt and TGF-β pathways mediate the regorafenib resistance.

Publisher

Frontiers Media SA

Subject

Cell Biology,Developmental Biology

Reference66 articles.

1. Context-dependent EMT programs in cancer metastasis.;Aiello;J. Exp. Med.,2019

2. Blocking TGF-β signaling to enhance the efficacy of immune checkpoint inhibitor.;Bai;Onco Targets Ther.,2019

3. Global trends and predictions in hepatocellular carcinoma mortality.;Bertuccio;J. Hepatol.,2017

4. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial.;Bruix;Lancet,2017

5. P53 mutation as a source of aberrant beta-catenin accumulation in cancer cells.;Cagatay;Oncogene,2002

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phytochemicals as Potential Lead Molecules against Hepatocellular Carcinoma;Current Medicinal Chemistry;2024-10

2. CuET overcomes regorafenib resistance by inhibiting epithelial-mesenchymal transition through suppression of the ERK pathway in hepatocellular carcinoma;Translational Oncology;2024-09

3. Advances in hepatocellular carcinoma drug resistance models;Frontiers in Medicine;2024-07-31

4. Stabilization of TGF‐β Receptor 1 by a Receptor‐Associated Adaptor Dictates Feedback Activation of the TGF‐β Signaling Pathway to Maintain Liver Cancer Stemness and Drug Resistance;Advanced Science;2024-07-09

5. COL5A2 drives regorafenib resistance-induced metastatic phenotype via reducing LIFR expression in hepatocellular carcinoma;Acta Biochimica et Biophysica Sinica;2024-05-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3